Article
Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
PloS one - 1 Jan 2016
Lu Jie, Cowperthwaite Matthew C, Burnett Mark G, Shpak Max
Abstract excerpt
Glioblastoma multiforme (GBM) is the most common and aggressive adult primary brain cancer, with <10% of patients surviving for more than 3 years. Demographic and clinical factors (e.g. age) and individual molecular biomarkers have been associated with prolonged survival in GBM patients. However, comprehensive systems-level analyses of molecular profiles associated with long-term survival (LTS) in GBM patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
